Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aimei Health Technology (AFJK) Preferred Stock Liabilities (2023 - 2025)

Aimei Health Technology (AFJK) has 3 years of Preferred Stock Liabilities data on record, last reported at $45.4 million in Q3 2025.

  • On a quarterly basis, Preferred Stock Liabilities fell 37.46% to $45.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $45.4 million, a 37.46% decrease, with the full-year FY2024 number at $73.8 million, up 5.57% from a year prior.
  • Preferred Stock Liabilities reached $45.4 million in Q3 2025 per AFJK's latest filing, up from $44.5 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for AFJK hit a ceiling of $73.8 million in Q4 2024 and a floor of $43.6 million in Q1 2025.
  • A 3-year average of $61.6 million and a median of $70.3 million in 2023 define the central range for Preferred Stock Liabilities.
  • Peak YoY movement for Preferred Stock Liabilities: increased 5.57% in 2024, then plummeted 38.42% in 2025.
  • Tracing AFJK's Preferred Stock Liabilities over 3 years: stood at $69.9 million in 2023, then grew by 5.57% to $73.8 million in 2024, then crashed by 38.41% to $45.4 million in 2025.
  • Business Quant data shows Preferred Stock Liabilities for AFJK at $45.4 million in Q3 2025, $44.5 million in Q2 2025, and $43.6 million in Q1 2025.